n-(n-benzylpiperidin-4-yl)-4-iodobenzamide has been researched along with Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bowen, WD; John, CS; Vilner, BJ | 1 |
| Bowen, WD; Efange, SM; Gulden, ME; John, CS; Langason, RB; Moody, TW; Vilner, BJ | 1 |
2 other study(ies) available for n-(n-benzylpiperidin-4-yl)-4-iodobenzamide and Breast Neoplasms
| Article | Year |
|---|---|
Synthesis and characterization of [125I]-N-(N-benzylpiperidin-4-yl)-4- iodobenzamide, a new sigma receptor radiopharmaceutical: high-affinity binding to MCF-7 breast tumor cells.
Topics: Animals; Benzamides; Binding Sites; Breast Neoplasms; Guinea Pigs; Humans; Iodine Radioisotopes; Piperidines; Radionuclide Imaging; Receptors, sigma; Tumor Cells, Cultured | 1994 |
Synthesis and pharmacological characterization of 4-[125I]-N-(N-benzylpiperidin-4-yl)-4-iodobenzamide: a high affinity sigma receptor ligand for potential imaging of breast cancer.
Topics: Affinity Labels; Animals; Benzamides; Breast Neoplasms; Cell Membrane; Female; Humans; Iodine Radioisotopes; Isomerism; Kinetics; Male; Piperidines; Radionuclide Imaging; Rats; Rats, Wistar; Receptors, sigma; Sensitivity and Specificity; Tissue Distribution; Tumor Cells, Cultured | 1995 |